Ocuphire Pharma | DEF 14A: Definitive information statements
17:04 ET
Ocuphire Pharma | ARS: Annual Report to Security Holders
16:51 ET
Ocuphire Pharma | DEFA14A: Others
16:46 ET
Ocuphire Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 19 17:30 ET
Ocuphire Pharma | 8-K: Current report
Apr 17 16:26 ET
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Pepose Jay
Apr 15 16:15 ET
Ocuphire Pharma | 8-K: Current report
Mar 27 16:30 ET
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer SCHACHLE JOSEPH K
Mar 25 16:50 ET
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jhaveri Nirav S.
Mar 25 16:44 ET
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George
Mar 20 16:23 ET
Ocuphire Pharma | 10-K: Annual report
Mar 8 17:26 ET
Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
Mar 8 08:25 ET
Ocuphire Pharma | 424B3: Prospectus
Feb 16 16:33 ET
Ocuphire Pharma | 8-K: Current report
Feb 16 16:07 ET
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jhaveri Nirav S.
Feb 14 18:38 ET
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jayagopal Ashwath
Feb 14 18:38 ET
Ocuphire Pharma | 3: Initial statement of beneficial ownership of securities-Officer Jhaveri Nirav S.
Feb 14 18:38 ET
Ocuphire Pharma | 3: Initial statement of beneficial ownership of securities-Officer Jayagopal Ashwath
Feb 14 18:33 ET
Ocuphire Pharma | EFFECT: Others
Jan 24 06:04 ET
Ocuphire Pharma | CORRESP: CORRESP
Jan 22 22:40 ET
No Data
No Data